A $2.6 Million Experiment to Map How the Female Body Ages Across the Menstrual Cycle
Kate Tolo becomes one of the most measured women in history, tracking 1,900 biomarkers across hormones, sleep, metabolism, and fertility.
Summary
Bryan Johnson introduces Kate Tolo, a collaborator who helped build the Blueprint longevity protocol and is now the subject of a $2.6 million female health experiment. Over an extended period, Kate will track 1,900 biomarkers across 16 biological systems, generating nearly 15 million data points using more than 50 measurement devices. The experiment is designed to map how the female body changes across the menstrual cycle — examining how hormones influence sleep quality, exercise response, nutrition, metabolic function, glucose regulation, recovery capacity, fertility, and aging trajectories. Kate also has endometriosis, making the project personally meaningful and potentially valuable for women with the condition. This represents one of the most comprehensive longitudinal biological datasets ever collected on a woman, and could generate insights that are broadly applicable to female longevity science — a historically underfunded area of research.
Detailed Summary
Women have been systematically underrepresented in longevity and performance research, leaving major gaps in understanding how female-specific biology — menstrual cycling, hormonal fluctuation, endometriosis, and reproductive aging — interacts with interventions that are broadly recommended for healthspan. This experiment attempts to close some of those gaps through unprecedented measurement depth applied to a single subject.
Kate Tolo, who helped develop Bryan Johnson's Blueprint protocol, is undertaking what may be the most comprehensive biological self-tracking experiment ever conducted on a woman. Over the course of the study, she will accumulate nearly 14.8 million data points across 1,900 biomarkers spanning 16 biological systems. More than 50 measurement devices will capture continuous and episodic data on sleep architecture, glucose dynamics, metabolic rate, exercise recovery, hormonal levels, and other physiological variables.
A central focus is mapping how the menstrual cycle phase modulates biological function. Hormonal fluctuations across the follicular and luteal phases are known to affect sleep quality, cardiovascular performance, insulin sensitivity, strength, and recovery — but the magnitude and individual variability of these effects are poorly characterized in fine-grained longitudinal data. This study will attempt to quantify those dynamics systematically.
Kate also has endometriosis, a chronic inflammatory condition affecting millions of women that is linked to immune dysfunction, metabolic disruption, and accelerated reproductive aging. Her participation introduces the possibility of generating biomarker-level insights into how endometriosis interacts with longevity-relevant physiological systems.
The study is a single-subject observational experiment and will not produce randomized clinical evidence. Its value lies in hypothesis generation and in demonstrating what comprehensive female longevity phenotyping looks like at scale. If the dataset is made accessible to researchers, it could anchor future comparative and interventional work in female longevity science.
Key Findings
- The experiment will collect 14.8 million data points across 1,900 biomarkers and 16 biological systems in one woman.
- Menstrual cycle phase effects on sleep, glucose, metabolism, exercise response, and recovery will be systematically mapped.
- Kate's endometriosis adds a clinically relevant chronic inflammatory context to the longevity measurements.
- Over 50 wearable and diagnostic devices will enable continuous and episodic tracking across the full experiment.
- The project represents one of the largest investments in female-specific longevity phenotyping to date at $2.6 million.
Methodology
This is a single-subject longitudinal observational study applying deep phenotyping to one woman over an extended period. Data collection spans wearables, clinical diagnostics, and continuous monitors across 16 biological systems. No control group or randomization is described; this is a self-tracking and hypothesis-generation project.
Study Limitations
This is a single-subject case study; findings cannot be statistically generalized to other women. The summary is based on a YouTube video description rather than a peer-reviewed protocol, so methodological rigor cannot be fully assessed. Selection bias is inherent — Kate is already deeply embedded in an elite longevity protocol, limiting applicability to average populations.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: